Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jul 3, 2008

PerkinElmer Creates Center to Advance Cord Blood Stem Cell Studies

  • PerkinElmer has established the ViaCord Research Institute™ (VRI™) to focus on investigating potential uses of umbilical cord blood-derived stem cells.

    VRI will concentrate on supporting science, technology, and medical treatments using cord blood stem cells in five key areas: cord blood technologies, emerging stem cell therapies, genetic screening, product development and related transplants.

    The institute will be led by a team of scientists and physicians including leading experts in the areas of stem cell biology, maternal-fetal medicine, obstetrics and gynecology, transplant medicine, and genetics.

    Cord blood is a noncontroversial source of stem cells with proven effect in treating more than 70 serious diseases including many cancers and immunodeficiencies, according to the PerkinElmer.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »